한국유니온제약
080720KOSDAQ의약품 제조업59.0 / 100
Reference Date: 2026-04-13
Company InformationBased on 2025 Annual Report
Business Overview
Korea Union Pharmaceutical focuses on manufacturing and selling specialty pharmaceuticals, exporting finished drugs, and providing CMO (contract manufacturing) services. The company specializes in antibiotics, cardiovascular, and musculoskeletal products, leveraging its GMP facilities and R&D efforts to enhance profitability. It has expanded exports to regions such as the Middle East, Southeast Asia, and South America, and is further expanding its CMO business and product portfolio through a newly completed factory.
Number of Employees
123people
Average Salary
39.2M KRW
Score Calculation Basis
Detailed Financial Score
94.9x industry avg (excellent)
Half of industry avg (excellent)
Avg ▼23.9% (2-year basis)
Avg ▼92.6% (2-year basis)
Avg ROE 88.4% (improving, 3yr)
Detailed News Sentiment
- Neutral부광약품, 베일 벗은 매출 107억원 출처..."글로벌 기술 수출"
부광약품 자회사 콘테라파마가 룬드벡으로부터 선급금 107억원을 수령하며 글로벌 기술 수출 성과를 냈다.
Detailed Momentum
52w mid range (50%)
1m 0% (flat)
Volume flat
Detailed Disclosure
- Neutral기타경영사항(자율공시) (상장폐지결정 등 효력정지 가처분 신청)2026-04-06
- Neutral주권매매거래정지 (투자자 보호)2026-04-06
- Neutral기타시장안내 (정리매매 보류 관련)2026-04-06
- Neutral기타시장안내 (코스닥시장위원회 개최 결과 및 상장폐지 결정 안내)2026-04-03
- Neutral주권매매거래정지해제 (상장폐지에 따른 정리매매 개시)2026-04-03
